Dr. Sadiq was the speaker at journal club this week. He presented the article: "Intravenous gammaglobulin suppresses inflammation through a novel Th2 pathway". The discussion focused on the mechanism of action of IVIg in autoimmune diseases. IVIg, which is a blood product of pooled immunoglobulins, is a treatment for various autoimmune diseases including MS, however it is not FDA approved for the treatment of MS.
Healing MS Newsletter
IMSMP is excited to launch this first issue of our new newsletter: HEALING MS.
